Magenta Therapeutics Inc.
News
Q2 2023 EPS Estimates for Magenta Therapeutics, Inc. Increased by Wedbush (NASDAQ:MGTA)
Ticker Report Magenta Therapeutics, Inc. (NASDAQ:MGTA Get Rating) Stock analysts at Wedbush increased their Q2 2023 earnings estimates for Magenta Therapeutics in a research report issued to clients and investors on Tuesday, May 16th. Wedbush analyst D. Nierengarten now anticipates that the ...\n more…
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA
PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGTA, CHRA, STSA PR Newswire NEW YORK, May 18, 2023 NEW YORK, May 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following...\n more…
Magenta Therapeutics, Inc. Expected to Earn Q1 2023 Earnings of ($0.41) Per Share (NASDAQ:MGTA)
Ticker Report Magenta Therapeutics, Inc. (NASDAQ:MGTA Get Rating) Equities researchers at Wedbush cut their Q1 2023 EPS estimates for shares of Magenta Therapeutics in a research note issued to investors on Wednesday, May 3rd. Wedbush analyst D. Nierengarten now forecasts that the company will ...\n more…
Wedbush Equities Analysts Cut Earnings Estimates for Magenta Therapeutics, Inc. (NASDAQ:MGTA)
Zolmax Magenta Therapeutics, Inc. (NASDAQ:MGTA Get Rating) Stock analysts at Wedbush cut their Q1 2023 earnings per share estimates for Magenta Therapeutics in a report released on Wednesday, May 3rd. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings of ($0.41) per share for...\n more…
Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus
PR Newswire Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus Shareholder Alert: Ademi LLP investigates whether Magenta Therapeutics, Inc. has obtained a Fair Price in its transaction with Dianthus PR Newswire MILWAUKEE, May...\n more…
MAGENTA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Magenta Therapeutics, Inc. - MGTA
Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Magenta Therapeutics, Inc. (NasdaqGM: MGTA) with Dianthus Therapeutics, Inc. pursuant to which Magenta shareholders are expected to own...\n more…